Grit Andersen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Diabetes, obesity & metabolism

Advances in therapy

Profil Institute for Metabolic Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Profil Institute for Metabolic Research Apr 01 2013

Germany

Director Clinical Pharmacology

Publications

Grit Andersen, Rosy Eloy, Tim Heise, Martin Gaudier, Claire Mégret, Cyril Seroussi, You-Ping Chan, Olivier Soula, Matthew C Riddle, J Hans DeVries
ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes. Diabetes, obesity & metabolism (2024)
Wei Chen, Jia Lu, Leona Plum-Mörschel, Grit Andersen, Eric Zijlstra, Anshun He, Tian Xie, Longling Li, Chunyue Hao, Zhongru Gan, Tim Heise
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU- und US-sourced reference insulins. Diabetes, obesity & metabolism (2023)
Grit Andersen, Gursharan Singh, Sundara Moorthi Nainar Murugesan, Rajesh Gogineni, Nirant Sharma, Jayanti Panda, Ashwani Marwah, Subramanian Loganathan, Sandeep N Athalye
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin N with US-licensed Humulin® N formulation in healthy subjects: Results from the RHINE-2 (Recombinant Human INsulin Equivalence-2) study. Diabetes, obesity & metabolism (2023)
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You-Ping Chan, Olivier Soula, Matthew C Riddle
A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Grit Andersen, Gursharan Singh, Sundara Moorthi Nainar Murugesan, Rajesh Gogineni, Nirant Sharma, Jayanti Panda, Ashwani Marwah, Subramanian Loganathan, Sandeep N Athalye
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar insulin N with US-licensed Humulin® N formulation in healthy subjects: Results from the RHINE-2 (Recombinant Human INsulin Equivalence-2) study. Diabetes, obesity & metabolism (2023)
Grit Andersen, Gursharan Singh, Sundara Moorthi Nainar Murugesan, Rajesh Gogineni, Nirant Sharma, Jayanti Panda, Ashwani Marwah, Subramanian Loganathan, Sandeep N Athalye
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar insulin N with US-licensed Humulin® N formulation in healthy subjects: Results from the RHINE-2 (Recombinant Human INsulin Equivalence-2) study. Diabetes, obesity & metabolism (2023)
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You-Ping Chan, Olivier Soula, Matthew C Riddle
A co-formulation of pramlintide and insulin A21G (ADO09) improves post-prandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Grit Andersen, Grégory Meiffren, Susanne Famulla, Tim Heise, Aymeric Ranson, Cyril Seroussi, Rosy Eloy, Martin Gaudier, Richard Charvet, You-Ping Chan, Olivier Soula, J Hans DeVries
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes. Diabetes, obesity & metabolism 23 (4) (2021)
Grit Andersen, Leona Plum-Mörschel, Paul D Hockings, Anni Morsing, Mads S Palle, Olivia Svolgaard, Anne Flint
Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data. Advances in therapy 37 (12) (2020)

Grit Andersen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Grit Andersen